In this context, we identified the hsa-miR-150-5p/CD276 ratio as one of the most prognostic in lung adenocarcinoma (TCGA-LUAD), whereby hsa-miR-150-5p is targeting CD276 (also known as B7-H3) and is inversely associated with overall survival (Use Case S2). Here, CD276 is linked to lung adenocarcinoma.